financetom
Business
financetom
/
Business
/
--Shuttle Pharmaceuticals Soars Premarket Following Completion of Phase 2 Glioblastoma Trial Site Enrollment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Shuttle Pharmaceuticals Soars Premarket Following Completion of Phase 2 Glioblastoma Trial Site Enrollment
Nov 3, 2024 1:27 PM

05:56 AM EDT, 10/29/2024 (MT Newswires) --

Price: 2.1806, Change: +0.85, Percent Change: +63.95

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nordson Closes Atrion Acquisition
Nordson Closes Atrion Acquisition
Aug 21, 2024
09:01 AM EDT, 08/21/2024 (MT Newswires) -- Nordson ( NDSN ) said Wednesday it has closed the acquisition of medical device manufacturer Atrion ( ATRI ) . In May, Nordson ( NDSN ) said it agreed to buy Atrion ( ATRI ) for $460 per share in cash. Price: 241.00, Change: +1.53, Percent Change: +0.64 ...
Monopar Receives Clearance in Australia for Phase 1 Trial of Radiopharmaceutical in Advanced Cancers
Monopar Receives Clearance in Australia for Phase 1 Trial of Radiopharmaceutical in Advanced Cancers
Aug 21, 2024
08:50 AM EDT, 08/21/2024 (MT Newswires) -- Monopar Therapeutics ( MNPR ) said Wednesday it has received clearance from Australia's Human Research Ethics Committee to start a phase 1 therapeutic trial of its radiopharmaceutical MNPR-101-Lu. The MNPR-101-Lu trial will enroll patients with advanced solid cancers and will be a therapeutic follow-on study to its ongoing MNPR-101-Zr imaging and dosimetry trial,...
Atossa Therapeutics Doses First Patient in Breast Cancer Therapy Study
Atossa Therapeutics Doses First Patient in Breast Cancer Therapy Study
Aug 21, 2024
09:08 AM EDT, 08/21/2024 (MT Newswires) -- Atossa Therapeutics ( ATOS ) said Wednesday that it had dosed the first patient in a trial evaluating its experimental drug, (Z)-endoxifen, in combination with Eli Lilly's ( LLY ) abemaciclib as a neoadjuvant treatment for certain high-risk breast cancer patients. The study, which is part of the I-SPY network, will involve around...
Ford Stock Charges Higher On EV Strategy Shift: What Investors Need To Know
Ford Stock Charges Higher On EV Strategy Shift: What Investors Need To Know
Aug 21, 2024
Ford Motor Co ( F ) shares are getting a boost Wednesday morning after the company announced plans to broaden its electrification strategy. What To Know: Ford announced that it’s taking additional actions to deliver a profitable, capital-efficient and growing electric vehicle business, including adjusting the company’s North America vehicle roadmap to offer a range of electrification options aimed at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved